Frontlight ResearchEarly access
Trial site
University of Illinois Hospital & Health Sciences System
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia1 trial
- Glioblastoma1 trial
- Heart failure1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Prostate cancer1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 1/22 trials
- Phase 22 trials
- Phase 32 trials
- Phase 11 trial
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Iovance Biotherapeutics, Inc.2 trials
- BioNTech SE1 trial
- Daiichi Sankyo1 trial
- Genentech, Inc.1 trial
- Incyte Corporation1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Recruiting
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
Recruiting
Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure1 recruiting
- Metastatic breast cancer1 recruiting
- Prostate cancer1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Recruiting
Terminated
Site data: ClinicalTrials.govUpdated 12 Nov 2026